CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

In an era marked by rapid technological advancement and shifting job market expectations, ETS (Educational Testing Service) is doubling down on its mission to ...